PRG-PRO-001 is a Phase I, Randomized, Double-blind, Placebo-Controlled, Single Ascending Dose
(SAD) Study including a food interaction study, followed by a Multiple Ascending Dose (MAD)
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Profile of
Progerinin in Healthy Volunteers. This is a first-in-human study. The study aims to determine
the safety and tolerability of Progerinin after single and multiple doses in healthy
volunteers and to evaluate the pharmacokinetics (PK) of Progerinin after single and multiple
dose administrations in healthy volunteers.